News Feed
Citius Pharmaceuticals Announces Improved Design and Expansion of Intellectual Property for Mino-Wrap
Expansion of patents granted to The University of Texas System on behalf of M. D. Anderson Cancer Center […]
News Feed
News Feed
XORTX Appoints Dr. David Sans in New York as Director Corporate Development
Dr. David Sans stated, “With forty million Americans living with kidney diseases and 700,000 having kidney failure, millions of lives are impacted by kidney-related illnesses. […]
News Feed
XORTX Partners with Mount Sinai’s Icahn School of Medicine on US-based Clinical Trial in COVID-19
● Exploring Elevated Uric Acid in Acute Kidney Injury from COVID-19 ● […]
News Feed
VICTORIA GOLD’S EAGLE GOLD MINE ACHIEVES SIGNIFICANT SAFETY MILESTONE
Whitehorse, YT / July 27, 2020 / Victoria Gold Corp. (TSX-VGCX) (“Victoria” or the “Company”), is pleased to announce a major safety accomplishment exceeding two years without a Lost Time Incident (“LTI”) at the Eagle […]
News Feed
Citius Forms Scientific Advisory Board for the Planned Development of its Proprietary Treatment for Acute Respiratory Disease Associated with COVID-19
– Pulmonology opinion leaders in ARDS therapies will bring invaluable insight in Company’s clinical trial design CRANFORD, N.J., July 22, 2020 /PRNewswire/ — Citius Pharmaceuticals, Inc. (“CITIUS”) (“Company”) (NASDAQ: CTXR), a specialty pharmaceutical company focused on developing and […]
News Feed
XpresSpa Group Provides Business Update
Significantly Strengthened Balance Sheet through Recent Capital Raises and Debt Reduction
Launched COVID-19 Testing at JFK International Airport on June 22nd
Files SEC Form 10-Q for the First Quarter ending March 31, 2020 […]
News Feed
HAPPY CANADA DAY – VICTORIA GOLD DECLARES COMMERCIAL PRODUCTION AT THE EAGLE GOLD MINE, YUKON, CANADA
Whitehorse, YT / July 1, 2020 / Victoria Gold Corp. (TSX-VGCX) (“Victoria” or the “Company”) is pleased to provide an update regarding commercial production and Covid-19 protocols as production continues at the Eagle Gold Mine […]
News Feed
Citius Receives FDA Response on Pre-Investigational New Drug Application for its Induced Mesenchymal Stem Cells to Treat Acute Respiratory Distress Syndrome in Patients with COVID-19
– FDA provides very specific guidelines to study iPSC-derived MSCs – Company intends to submit an IND application for its iMSC therapy for patients with ARDS associated with COVID-19 CRANFORD, N.J., June 26, 2020 /PRNewswire/ […]
News Feed
Soligenix Completes Enrollment in its Pivotal Phase 3 Clinical Trial of SGX942 for the Treatment of Oral Mucositis
PRINCETON, N.J., June 24, 2020 /PRNewswire/ — Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced […]
News Feed
KUSHCO STRENGTHENS BALANCE SHEET AND LIQUIDITY THROUGH PARTIAL CONVERSION OF SENIOR UNSECURED NOTE
Company Proactively Reduces Debt by Converting 18.5% of the Principal Amount of its Senior Note due April 2021 into Equity with Limited Dilution and Zero Warrants CYPRESS, CA / ACCESSWIRE / June 10, 2020 / KushCo […]